BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2020
View Archived Issues
AHR inhibition suppresses Zika infection
Read More
[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer
Read More
[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM
Read More
EBV drives gastric cancer by rewiring host epigenomes
Read More
Suzhou Zelgen Biosciences identifies new MAP3K5 inhibitors
Read More
Dihydroorotate dehydrogenase inhibitors discovered at Janssen
Read More
Cascade (Shanghai) Pharmaceutical Technology patents AMPK activators
Read More
New PDE9 inhibitors synthesized at Nanjing TransThera Biosciences
Read More
Gruenenthal presents glucocorticoid receptor modulators
Read More
Series A financing to support ExeVir's development of VHH-72-Fc for COVID-19
Read More
Enrollment starts in phase IIa study of tegavivint in desmoid tumors
Read More
PIK3C2B blockade protects against ischemic stroke and preserves vascular integrity
Read More
FDA clears first IND application for RLS-0071
Read More
Reata announces investigator-sponsored trial of bardoxolone in patients with COVID-19
Read More
First patient dosed in investigator-initiated study of infigratinib in recurrent glioblastoma
Read More
European Commission grants approval for Xenleta as treatment of CAP
Read More
COVACTA trial of Actemra in severe COVID-19-associated pneumonia misses endpoints
Read More
Phase III REFALS trial of oral levosimendan in ALS does not meet endpoints
Read More
Mucolipin-1 is a therapeutic target in Alzheimer's disease
Read More
Krystal begins phase III study of beremagene geperpavec for dystrophic epidermolysis bullosa
Read More
